SEC Form 4 · accession 0001437749-18-017039
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen L. Zaderej
Director
Period of report
Sep 13, 2018
Accepted (ET)
Sep 14, 2018 · 2:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionsF1 | $3.45 | Sep 13, 2018 | A | 70,000 | A | — | Sep 12, 2028 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 70,000 incentive stock options on September 13, 2018 (the "Grant Date"). The non-qualified stock options will vest in equal annual installments over three years beginning on the first anniversary of the Grant Date.